Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Announcement
Sort By
Newest First
1 / 6
LabCorp
Announcement
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans
LabCorp
PR-02-25-NI-24
Feb 25, 2025
Vanda Pharmaceuticals
Announcement
Vanda Pharmaceuticals Announces the Publication of an Article "Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
Vanda Pharmaceuticals
PR-02-25-NI-25
Feb 24, 2025
Bio-Techne Corporation
Announcement
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
Bio-Techne Corporation
PR-02-25-NI-17
Feb 19, 2025
Sano Chemicals Inc
Announcement
Sano Chemicals Inc Announces Approval to Start Phase 1 MAD Study
Sano Chemicals Inc
PR-01-25-NI-30
Feb 04, 2025
NorthX Biologics
Announcement
NorthX Biologics Appoints Patrick DePalma Senior Vice President of North American Business Development
NorthX Biologics
PR-01-25-NI-22
Jan 20, 2025
Cryoport
Announcement
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
Cryoport
PR-01-25-NI-15
Jan 16, 2025
Nona Biosciences
Announcement
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
Nona Biosciences
PR-01-25-NI-02
Jan 03, 2025
Theravance Biopharma
Announcement
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Theravance Biopharma
PR-12-24-NI-137
Dec 17, 2024
Karyopharm Therapeutics Inc.
Announcement
Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications
Karyopharm Therapeutics Inc.
PR-12-24-NI-135
Dec 12, 2024
Bio-Techne Corporation
Large Molecule
Bio-Techne and ALZpath Announce Strategic Partnership to Advance Neurdegenerative Disease Research
Bio-Techne Corporation
PR-11-24-NI-109
Nov 20, 2024
Abbott
Announcement
Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
Abbott
PR-11-24-NI-108
Nov 19, 2024
Concerto Biosciences
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
Genomadix
Announcement
Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke
Genomadix
PR-11-24-NI-106
Nov 15, 2024
Flagship Pioneering
Announcement
Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio
Flagship Pioneering
PR-10-24-NI-97
Nov 13, 2024
Bio-Techne Corporation
Announcement
Bio-Techne To Present At Investor Conferences
Bio-Techne Corporation
PR-10-24-NI-87
Nov 08, 2024
World ADC
Announcement
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement
World ADC
PR-10-24-NI-77
Nov 08, 2024
I-Mab
Announcement
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
I-Mab
PR-10-24-NI-80
Nov 07, 2024
Precision Biologics
Clinical Trials
Precision Biologics to Announce Development of New Monoclonal Antibody (mAb) PB-223 at SITC, Houston, TX, November 7-8, 2024
Precision Biologics
PR-10-24-NI-78
Nov 07, 2024
Pharma Tech Industries
Announcement
Pharma Tech Industries Names Darrin T. Schellin New CEO
Pharma Tech Industries
PR-10-24-NI-69
Oct 30, 2024
SK bioscience
Announcement
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
SK bioscience
PR-10-24-NI-59
Oct 23, 2024
1 / 6
